aap Implantate AGの将来のP / E
aap Implantate AGの将来のP / Eは何ですか。
aap Implantate AGの将来のP / Eは-3.84です。
将来のP / Eの定義は何ですか。
未来比率P / E (株価収益率)は、企業の株価と今後12ヶ月間の1株当たり利益見込額との比率です。
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
XETRAのセクタHealth Careにおける将来のP / Eの企業と比べるaap Implantate AG
aap Implantate AGは何をしますか。
aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany, the United States, and internationally. It offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.
aap Implantate AGと類似の将来のp / e
- Wave Life Sciencesの将来のP / Eは-3.96です。
- Resverlogixの将来のP / Eは-3.95です。
- Evoke Pharma Incの将来のP / Eは-3.92です。
- Sotherly Hotels Incの将来のP / Eは-3.91です。
- Intellia Therapeutics Incの将来のP / Eは-3.88です。
- Peloton Interactive Incの将来のP / Eは-3.88です。
- aap Implantate AGの将来のP / Eは-3.84です。
- Pharnext SAの将来のP / Eは-3.84です。
- Tinka Resourcesの将来のP / Eは-3.83です。
- Trilogy International Partnersの将来のP / Eは-3.82です。
- Midas Goldの将来のP / Eは-3.82です。
- Agios Pharmaceuticals Incの将来のP / Eは-3.82です。
- Recon Technology Ltdの将来のP / Eは-3.80です。